Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Schools to start reopening after Nigeria mass abduction - 2German finance minister seeks better market access in China talks
- 3Rick Steves Recommends This German Town's Castle Hotel With Rhine River Views
- 4Famous Network programs in Europe and America
- 5What to know about cheese voluntarily recalled in 20 states
- Emotional wellness Matters: My Fight with Tension
- Dominating the Art of Composing: Creator Bits of knowledge
- This Flashy Old-School Design Trend From Italy Still Has A Place In Modern Kitchens
- The biggest black hole breakthroughs of 2025
- Bonk.fun’s April Fools Joke Targets Israel, Sparks Debate
- Lower-cost space missions like NASA's ESCAPADE are starting to deliver exciting science – but at a price in risk and trade‑offs
- Ski Resorts Universally: A Colder time of year Wonderland Guide
- Unraveling the Specialty of Picking Your Ideal Travel Objective
- Trouvez La Carte De Cr\u00e9dit Id\u00e9ale Pour Vos Besoins En Belgique
